Shima Mimura

914 total citations
41 papers, 495 citations indexed

About

Shima Mimura is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Shima Mimura has authored 41 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 15 papers in Molecular Biology and 14 papers in Epidemiology. Recurrent topics in Shima Mimura's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and MicroRNA in disease regulation (9 papers). Shima Mimura is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and MicroRNA in disease regulation (9 papers). Shima Mimura collaborates with scholars based in Japan, Somalia and United States. Shima Mimura's co-authors include Tsutomu Masaki, Joji Tani, Hisakazu Iwama, Takashi Himoto, Hideki Kobara, Hisaaki Miyoshi, Yasuyuki Suzuki, Keiichi Okano, Kei Nomura and Koji Fujita and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Gene.

In The Last Decade

Shima Mimura

34 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shima Mimura Japan 10 325 173 146 81 74 41 495
Longyi Zheng China 6 296 0.9× 138 0.8× 169 1.2× 163 2.0× 128 1.7× 20 507
Ersin Akgöllü Türkiye 14 373 1.1× 274 1.6× 133 0.9× 115 1.4× 57 0.8× 24 575
Aynur Bekar Türkiye 14 383 1.2× 277 1.6× 140 1.0× 107 1.3× 48 0.6× 20 569
Mio Endo Japan 11 310 1.0× 131 0.8× 81 0.6× 160 2.0× 63 0.9× 23 526
W-T Chen Taiwan 7 243 0.7× 215 1.2× 61 0.4× 81 1.0× 60 0.8× 12 439
Guangyan Wei China 10 158 0.5× 68 0.4× 86 0.6× 138 1.7× 117 1.6× 30 419
Zhao Yin-nong China 10 156 0.5× 112 0.6× 114 0.8× 77 1.0× 85 1.1× 24 406
Siyu Tan China 13 262 0.8× 103 0.6× 154 1.1× 89 1.1× 65 0.9× 29 548
Huimin Ma China 11 159 0.5× 95 0.5× 79 0.5× 81 1.0× 63 0.9× 44 389
Xuexiu Zhang China 11 189 0.6× 132 0.8× 52 0.4× 80 1.0× 67 0.9× 17 371

Countries citing papers authored by Shima Mimura

Since Specialization
Citations

This map shows the geographic impact of Shima Mimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shima Mimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shima Mimura more than expected).

Fields of papers citing papers by Shima Mimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shima Mimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shima Mimura. The network helps show where Shima Mimura may publish in the future.

Co-authorship network of co-authors of Shima Mimura

This figure shows the co-authorship network connecting the top 25 collaborators of Shima Mimura. A scholar is included among the top collaborators of Shima Mimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shima Mimura. Shima Mimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mimura, Shima, Asahiro Morishita, Kyoko Oura, et al.. (2025). Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets. Journal of Clinical Medicine. 14(23). 8503–8503.
2.
Mimura, Shima, Asahiro Morishita, Kyoko Oura, et al.. (2025). Galectins and Liver Diseases. International Journal of Molecular Sciences. 26(2). 790–790. 2 indexed citations
3.
Tadokoro, Tomoko, Hung Tai, Kei Takuma, et al.. (2025). Do Patients With Alcoholic Cirrhosis Accurately Recognize Their Alcohol Tolerance? A Study Comparing Self‐Perception and ALDH2/ADH1B Genotype. Hepatology Research. 56(3). 322–329.
4.
Tadokoro, Tomoko, Miwa Kawanaka, Kazuhiro Takahashi, et al.. (2025). A Noninvasive Method of Diagnosing Metabolic Dysfunction-Associated Steatohepatitis Using Cytokeratin-18 Fragment and FIB-3 Index. Diagnostics. 15(8). 1023–1023.
5.
Sasaki, Katsuhiro, Shintaro Fujihara, Hisakazu Iwama, et al.. (2025). The Polyphenol (−)-Epigallocatechin-3-gallate (EGCG) Inhibits the Proliferation of Gastric Cancer Cells and Alters microRNA Signatures. Anticancer Research. 45(7). 2925–2936.
6.
Oura, Kyoko, Asahiro Morishita, Kei Takuma, et al.. (2025). Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma. Journal of Gastroenterology. 60(6). 770–782. 1 indexed citations
7.
Tadokoro, Tomoko, Takako Nomura, Koji Fujita, et al.. (2024). Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients. BMC Gastroenterology. 24(1). 123–123. 1 indexed citations
8.
Tadokoro, Tomoko, Joji Tani, Kei Takuma, et al.. (2024). Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis. Scientific Reports. 14(1). 10784–10784. 6 indexed citations
9.
Oura, Kyoko, Asahiro Morishita, Kei Takuma, et al.. (2023). Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival. Cancer Medicine. 12(24). 22023–22037. 2 indexed citations
10.
11.
Oura, Kyoko, Asahiro Morishita, Joji Tani, et al.. (2023). Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy. Cancers. 15(6). 1834–1834. 4 indexed citations
12.
Himoto, Takashi, et al.. (2023). Involvement of essential trace elements in the pathogenesis of hepatitis C virus‑related chronic liver disease and nonalcoholic steatohepatitis. Experimental and Therapeutic Medicine. 27(1). 19–19. 2 indexed citations
13.
Takuma, Kei, Shintaro Fujihara, Koji Fujita, et al.. (2022). Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines. International Journal of Molecular Sciences. 23(3). 1667–1667. 3 indexed citations
14.
Fujihara, Shintaro, Hisakazu Iwama, Koji Fujita, et al.. (2022). Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells. Anticancer Research. 42(3). 1263–1275. 6 indexed citations
15.
16.
17.
Morishita, Asahiro, Koji Fujita, Hisakazu Iwama, et al.. (2020). Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma. American Journal of Physiology-Gastrointestinal and Liver Physiology. 318(3). G401–G409. 29 indexed citations
18.
Tadokoro, Tomoko, Asahiro Morishita, Teppei Sakamoto, et al.. (2017). Galectin-9 ameliorates fulminant liver injury. Molecular Medicine Reports. 16(1). 36–42. 10 indexed citations
19.
Mimura, Shima, Hisakazu Iwama, Kiyohito Kato, et al.. (2014). Profile of microRNAs associated with aging in rat liver. International Journal of Molecular Medicine. 34(4). 1065–1072. 29 indexed citations
20.
Kato, Kiyohito, Jian Gong, Hisakazu Iwama, et al.. (2012). The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo. Molecular Cancer Therapeutics. 11(3). 549–560. 198 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Longyi Zheng Breakdown of academic impact, for papers by Ersin Akgöllü Breakdown of academic impact, for papers by Aynur Bekar Breakdown of academic impact, for papers by Mio Endo Breakdown of academic impact, for papers by W-T Chen Breakdown of academic impact, for papers by Guangyan Wei Breakdown of academic impact, for papers by Zhao Yin-nong Breakdown of academic impact, for papers by Siyu Tan Breakdown of academic impact, for papers by Huimin Ma Breakdown of academic impact, for papers by Xuexiu Zhang
Rankless by CCL
2026